HLS Therapeutics Inc

HLS Therapeutics Inc., a specialty pharmaceutical company, focuses on acquiring and commercializing pharmaceutical products in the specialty central nervous system and cardiovascular markets. It markets Clozaril, a pharmaceutical product used in the treatment of schizophrenia in Canada and the United States. Show More...

  • Website http://www.hlstherapeutics.com
  • Sector Healthcare
  • Industry Drug Manufacturers-Specialty & Generic
  • Last Quote 4.96 CAD
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD 0.2 0.6 0.82 0.49 0.65 -0.1 -0.6 -0.24 -0.92 -0.67 -0.53
    Dividends USD 0.1 0.24 0.23 0.16 0.04 0.15 0.15
    Payout Ratio % * 17.1 28.8 43.2 39.9
    Shares Mil 23.0 20.0 20.0 20.0 19.0 18.0 25.0 25.0 27.0 29.0 31.0
    Book Value Per Share * CAD 1.63 1.53 2.03 2.27 2.58 2.81 2.69 2.54 8.33 7.93 7.35
    Free Cash Flow Per Share * CAD 0.96 0.84 0.94 1.11 0.8 0.4 -0.010 -0.13 1.88 1.47
    Return on Assets % -1.49 26.22 35.25 18.63 22.12 -3.99 -3.36 -2.97 -7.18 -6.25 -5.18
    Financial Leverage (Average) 1.37 1.41 1.21 1.35 1.28 1.02 1.02 2.13 1.93 1.79 1.81
    Return on Equity % -2.12 36.43 45.86 23.88 29.14 -4.76 -3.43 -5.94 -14.64 -11.61 -9.62
    Return on Invested Capital % -1.33 35.93 45.66 23.5 28.39 -5.23 -4.14 4.58 -3.6 -4.85 -3.87
    Interest Coverage 6.67 409.85 0.95 -0.68 -1.66 -1.45
    Current Ratio 2.46 2.53 5.26 3.59 4.46 58.64 56.38 1.88 0.83 1.34 1.36
    Quick Ratio 2.21 2.38 5.12 3.52 4.42 58.41 56.13 1.79 0.74 1.25 1.13
    Debt/Equity 0.010 0.76 0.58 0.49 0.5